Please enter the email address you used to register, then we will send you a link to choose a new password
XYZ: 10% | Block Will Replace Hess Corp. In The S&P 500 Effective Prior To The Opening Of Trading On Wednesday, July 23
GCTK: 105% | Glucotrack Repurchases Over 90% Of Series A Warrants From $10M Public Offering, Advancing Capital Strategy And Diabetes Device Development
HSDT: 89% | Helius Medical Reports Outcome From PoNS SRP Supporting Planned FDA Submission Seeking Indication For Gait And Balance Deficit In Patients With Chronic Symptoms Of Stroke Under Current Breakthrough Device Designation
Posted In: GCTK HSDT XYZ